COMMUNIQUÉS West-GlobeNewswire

B-Temia and Wistron Announce the Incorporation of B-Temia Asia
28/11/2018
B-Temia Asia will launch human mobility device Keeogo(TM) in the Asia Market QUÉBEC CITY, Nov. 27, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. today announced the official incorporation of B-Temia Asia Pte. Ltd., as a result [...]
B-Temia et Wistron annoncent la création de B-Temia Asia
28/11/2018
B-Temia Asia lancera le Keeogo(TM), son appareil de mobilité humaine sur le marché asiatique QUÉBEC, 27 nov. 2018 (GLOBE NEWSWIRE) -- B-Temia Inc. a annoncé aujourd’hui la création officielle de B-Temia Asia Pte. Ltd., [...]
Abattis Comments on BCSC Temporary Order
28/11/2018
VANCOUVER, British Columbia, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) comments on the news release regarding the British Columbia Securities [...]
Coherus BioSciences Announces New Employment Inducement Grants
28/11/2018
REDWOOD CITY, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective November 14, 2018, the compensation committee of the company’s board of directors granted [...]
Agility Health Announces Director Resignation
27/11/2018
Not for distribution to United States Newswire Services or for dissemination in the United States HAMILTON, Ontario, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“Agility Health” or, the “Company [...]
MacroGenics Announces Participation in Three Investor Conferences
27/11/2018
ROCKVILLE, MD, Nov. 27, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
ContraVir Pharmaceuticals to Present CRV431 Preclinical Data at the Anti-Fibrotic Drug Development Summit
27/11/2018
EDISON, N.J., Nov. 27, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of liver [...]
Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis
27/11/2018
Mechelen, Belgium; 27 November 2018, 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announced today that the FDA has granted GLPG1972/S201086 Fast Track designation for the treatment of patients with [...]
Acura Pharmaceuticals Announces Third Quarter 2018 Financial Results
27/11/2018
PALATINE, Ill., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and nine [...]
Catalyst Pharmaceuticals Announces Firdapse® (amifampridine) New Drug Application Continues Under Review
27/11/2018
FDA PDUFA goal date remains tomorrow, November 28, 2018 CORAL GABLES, Fla., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals Inc. (Nasdaq:CPRX) today reports that no decision has yet been received from the [...]
Representatives of Fulgent Genetics to Participate in the Piper Jaffray 30th Annual Healthcare Conference
27/11/2018
TEMPLE CITY, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming Hsieh and its Chief [...]
EyePoint Pharmaceuticals Appoints Ron Honig, Esq., as SVP, General Counsel & Company Secretary
27/11/2018
- Industry veteran who brings over 25 years of legal expertise in the medical device industry to newly created position - WATERTOWN, Mass., Nov. 27, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT [...]
Assure Holdings Reports Third Quarter 2018 Financial Results
27/11/2018
Revenue Increased 57% to $6.1 Million on Managed Case Growth of 90% DENVER, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative [...]
CORRECTION: Psoria-Shield, Inc. and Neo Phototherapy LLC Developing Next Generation LED Phototherapy Device
27/11/2018
HOFFMAN ESTATES, IL, Nov. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Wellness Center USA, Inc. (OTCQB: WCUI ) and Psoria-Shield, Inc. (PSI) today announced the formation of a Joint Venture between Psoria-Shield, [...]
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress
27/11/2018
- Epidiolex ® (cannabidiol) oral solution (CV), first FDA-approved plant-derived cannabinoid medicine launched in the U.S. - - Conference call today at 4:30 p.m. EST - LONDON and CARLSBAD, Calif., Nov. 27, 2018 (GLOBE [...]
Stryker announces pricing of €2.25 billion senior notes offering
27/11/2018
Kalamazoo, Michigan, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that it has priced the following notes: (i) €550 million aggregate principal amount of the Company’s 1.125% Notes due 2023 (the “ [...]
Theratechnologies’ CFO to Present at 30th Annual Piper Jaffray and at BMO Healthcare Conferences
27/11/2018
MONTREAL, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer will present at the 30 th [...]
Le chef de la direction financière de Theratechnologies présentera lors des conférences annuelles sur le secteur de la santé de Piper Jaffray et de BMO
27/11/2018
MONTRÉAL, 27 nov. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que Philippe Dubuc, vice-président sénior et chef de la direction financière fera une présentation [...]
Corizon Health Secures Investment of More Than $100 Million to Strengthen Balance Sheet
27/11/2018
BRENTWOOD, Tenn., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Corizon Health, the nation’s leading provider of correctional health services, announced the completion of a transaction that eliminates more than $100 million of [...]

Pages